Sponsored Links
| Onset Therapeutics Launches HYLATOPIC™ Emollient Foam For Atopic Dermatitis |
 |
 |
 |
| Medical News - Dermatology | |||
|
Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, announced the FDA approval and commercial launch of HYLATOPIC™ Emollient Foam, a unique, non-steroidal prescription product indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. Read more: Dermatology News From Medical News Today
|